CEL-SCI CorpAdd to My Watchlist

CVM:USNYSEAmericanIndustry: Medical-Biomedical/Gene
  • 1.87
  • 0.07  3.85%
    Today's Change
  • 1.80
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 10/20/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding12 million
Market Cap$22 million
Return on Equity ttm--
Last DividendCVM:US does not pay a dividend
EPS: Year Actual ttm-1.762
EPS: Year Est. 9/17 ttm-1.140
EPS: Quarterly Actual -- -0.59
EPS: Quarterly Est. -- --
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate78.57
Company Description
CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer.
Net Income$-11 million
Total Assets$12 million
Web Sitewww.cel-sci.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!